Literature DB >> 2982972

Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection.

R M Douglas, J K Albrecht, H B Miles, B W Moore, R Read, D A Worswick, A J Woodward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2982972      PMCID： PMC7109831          DOI： 10.1093/infdis/151.4.731

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  15 in total

1.  Interfering with the real cold.

Authors:  G Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-31

2.  Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults.

Authors:  R M Douglas; H B Miles; B W Moore; P Ryan; C B Pinnock
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

3.  Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon.

Authors:  A S Monto; J K Albrecht; S A Schwartz
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

4.  Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.

Authors:  F G Hayden; D L Kaiser; J K Albrecht
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

Review 5.  Common colds. Causes, potential cures, and treatment.

Authors:  H G Saroea
Journal:  Can Fam Physician       Date:  1993-10       Impact factor: 3.275

6.  Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families.

Authors:  A S Monto; S A Schwartz; J K Albrecht
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

7.  A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers.

Authors:  G A Tannock; S M Gillett; R S Gillett; R D Barry; M J Hensley; R Herd; A L Reid; N A Saunders
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

Review 8.  Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.

Authors:  Tony Velkov; Nusaibah Abdul Rahim; Qi Tony Zhou; Hak-Kim Chan; Jian Li
Journal:  Adv Drug Deliv Rev       Date:  2014-11-12       Impact factor: 15.470

Review 9.  Antimicrobial strategies: an option to treat allergy?

Authors:  Nikolaos G Papadopoulos; George N Konstantinou
Journal:  Biomed Pharmacother       Date:  2006-12-05       Impact factor: 6.529

10.  Biological response modifiers and infectious diseases: actual and potential therapeutic agents.

Authors:  J J Rusthoven
Journal:  Int J Antimicrob Agents       Date:  1994       Impact factor: 5.283
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.